自放大RNA:用于疫苗开发的多功能平台的优点和挑战
Thomas Vallet1,2, Marco Vignuzzi1,2
1A*STAR Infectious Diseases Labs (A*IDL), Agency for Science, Technology and Research (A*STAR), Singapore 138634, Singapore.
Viruses
|April 26, 2025
概括
自放大RNA (saRNA) 为疫苗提供了增强的抗原表达,但面临着挑战. 本综述探讨了saRNA的局限性和开发先进治疗方法的策略.
科学领域:
- 分子生物学分子生物学
- 疫苗学 疫苗学 疫苗学
- 生物技术是生物技术.
背景情况:
- 自放大RNA (saRNA) 是一种合成的核酸,用于在不产生病毒颗粒的情况下进行细胞内复制.
- saRNA技术是从alphavirus基因组中衍生出来的,保留了必不可少的非结构复制元素,同时结合了感兴趣的抗原.
研究的目的:
- 审查自我放大RNA (saRNA) 技术的主要局限性.
- 探索克服这些挑战的潜在策略.
- 为基于saRNA的治疗方法的未来设计提供见解.
主要方法:
- 关于自我放大RNA (saRNA) 技术的文献综述.
- 对saRNA与传统mRNA疫苗的优势进行分析.
- 识别和讨论saRNA目前的局限性.
主要成果:
- saRNA能够有效地进行细胞内放大,增强抗原表达,并允许较低的疫苗剂量.
- 发现了saRNA技术的关键局限性.
- 研究了克服这些局限性的潜在策略.
结论:
- 由于增强抗原表达和降低剂量要求,saRNA为疫苗开发提供了一个有前途的平台.
- 解决已识别的局限性对于推进saRNA技术至关重要.
- 获得的见解可以指导超越疫苗的saRNA治疗方法的开发.
相关概念视频
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...


